Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Therapeutics Says Results From Phase 1 Trial Confirm Amp945 Is Safe And Well Tolerated

Nov 18 (Reuters) - Amplia Therapeutics Ltd  ATX.AX :
    * AMPLIA THERAPEUTICS LTD - UNBLINDED RESULTS FROM PHASE 1 TRIAL CONFIRM
AMP945 IS
SAFE AND WELL TOLERATED AT ALL DOSES TESTED

Source text for Eikon:  ID:nASX3Jrh39 
Further company coverage:  ATX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news